Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06123390
Other study ID # 1000080735
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 11, 2023
Est. completion date October 31, 2024

Study information

Verified date November 2023
Source The Hospital for Sick Children
Contact Nancy M Dale, PhD
Phone 416-813-6486
Email nancy-m.dale@sickkids.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effect of the Responses to Illness Severity Quantification (RISQ) system implementation on mortality and processes of care in a nutritional program treating children 6 to 59 months of age with acute malnutrition in Ngouri, Chad.


Description:

The CRIMSON Study is a 12-month cluster randomized trial that will evaluate the effect of implementing the RISQ system compared with usual care on all-cause mortality, in children with acute malnutrition aged 6 to 59 months enrolled in the OptiMA nutrition program in Chad. The intervention is the RISQ System and the clusters are the individual health centres that are randomized with a ratio of 1:1, RISQ System: Usual care. The 12 month intervention period will begin following a run in phase in which sites randomized to intervention will introduce and establish the new practices and in which sites randomized to usual care will continue to provide usual care. The RISQ system is a scientifically developed clinical decision support tool that consists of: [1] the RISQ score; [2] documentation form; [3] score-matched recommendations and [4] an implementation package. The RISQ score, developed through our prospective observational study in Maiduguri Nigeria ((NCT04582773) ranges from 0 to 26 (high scores indicating greatest severity of illness). In the development dataset, the mean RISQ score on admission was 3.6 in hospital survivors and 7.3 for children dying <48hr of admission. RISQ scores <24hr before death had Area Under the Receiver Operating Characteristics Curve (AUROC) of 0.93. The RISQ score performed similarly well in children independent of their clinical conditions as a diagnosis-independent measure of severity of illness. Additionally, through a study of 903 hospitalized children with Severe Acute Malnutrition (SAM), the RISQ score could discriminate between points of escalation or de-escalation of care and can reflect illness severity in children throughout hospitalization. The documentation form provides visual representation of the sub-scores of each RISQ score items and guidance for score calculation. The score-matched recommendations of the RISQ system that are linked to the RISQ scores are derived from an expert panel of clinicians, with over 100 years of collective experience caring for acutely malnourished children, and provide guidance about intensity of care. This includes the frequency of observation, consideration of secondary review, inpatient admission, and transfer into / out of inpatient care areas where more intensive treatments are provided.The implementation package consists of theoretical and practical training modules including specific 'train the trainers' sessions for key personal involved in the implementing programs. The CRIMSON study is nested within the existing framework of the OptiMA nutritional program and observational study conducted by the Alliance for International Medical Action (ALIMA). The program involves health centres within Ngouri, a sub-prefecture of the Lake Region in Chad (and surrounding area) plus an inpatient unit at the Ngouri District Hospital providing care for children with acute malnutrition. Inclusion criteria for the OptiMA program are based on mid-upper arm circumference (MUAC) of <125mm and/or bilateral pitting oedema. Usual care in the OptiMA program is as follows: nutritional treatment to participants consists of Ready-to-use-Therapeutic Food (RUTF) adjusted based on their MUAC value throughout the duration of their care. Management of the children with acute illnesses follows the established approach for management of children with severe acute malnutrition using the World Health Organization (WHO) "danger signs" and Integrated Management of Childhood Illness (IMCI) algorithms to guide admission to hospital. Additionally, as part of the OptiMA program in Ngouri, pulse oximeters have been introduced in all health centres and inpatient care unit, following training by ALIMA. Included in the routine visits of the program is the measurement and documentation of each of the 7 RISQ score items [heart rate, respiratory rate, respiratory effort, oxygen saturation, temperature, level of consciousness and oxygen use (oxygen is currently only available in the inpatient care)] by nurses. The investigators anticipate that implementation of the RISQ system in a nutrition treatment program will improve sensitivity and specificity of clinical evaluation in determining which children require hospitalization, and what level of medical care within the in-patient unit is appropriate and in turn potentially reduce mortality.


Recruitment information / eligibility

Status Recruiting
Enrollment 20000
Est. completion date October 31, 2024
Est. primary completion date August 31, 2024
Accepts healthy volunteers No
Gender All
Age group 6 Months to 59 Months
Eligibility Inclusion Criteria: Children: 1. age: 6 to 59 months at enrolment on the day of their admission/re-admission to the OptiMA program 2. written consent to participate Front line staff providing care to patients enrolled in the Optima program: [1] Registered Nurses [2] Medical Doctors Exclusion Criteria: Children: 1. Children allergic to milk, peanuts and/or ready-to-use therapeutic food (RUTF) 2. Children not residing in one of the study areas.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
The Responses to Illness Severity Quantification (RISQ) System
The RISQ System involves: [1] the RISQ score: calculated routinely using the [2] documentation record and linked to [3] score-matched recommendations. Introduction into clinical care is supported by [4] the RISQ System implementation package. During the 2 month prior to implementation, front-line staff in the intervention arm will be trained on and will practice the use of the RISQ System .

Locations

Country Name City State
Chad Ngouri Ngouri

Sponsors (3)

Lead Sponsor Collaborator
The Hospital for Sick Children Alliance for International Medical Action, University of N'Djaména, Chad

Country where clinical trial is conducted

Chad, 

References & Publications (2)

Dale NM, Ashir GM, Maryah LB, Shepherd S, Tomlinson G, Briend A, Zlotkin S, Parshuram C. Development and an initial validation of the Responses to Illness Severity Quantification (RISQ) score for severely malnourished children. Acta Paediatr. 2022 Sep;111(9):1752-1763. doi: 10.1111/apa.16410. Epub 2022 Jun 3. — View Citation

Dale NM, Ashir GM, Maryah LB, Shepherd S, Tomlinson G, Briend A, Zlotkin S, Parshuram CS. Evaluating the Validity of the Responses to Illness Severity Quantification Score to Discriminate Illness Severity and Level of Care Transitions in Hospitalized Children with Severe Acute Malnutrition. J Pediatr. 2023 Nov;262:113609. doi: 10.1016/j.jpeds.2023.113609. Epub 2023 Jul 5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Lived experience of RISQ System implementation Lived experiences measured by open ended questions about strengths/weaknesses of RISQ System implementation added to frontline staff perception questionnaire at end of intervention period one time at end of 12 month implementation period
Other comparison of automated versus manual measurements of vital signs (Respiratory rate in breaths/min) Comparison determined by agreement between the two different methods for respiratory rate measurement During run-in phase prior to implementation of intervention, on average 2 months
Other comparison of automated versus manual measurements of vital signs (Temperature in degrees Celsius) Comparison determined by agreement between the two different methods for temperature measurement During run-in phase prior to implementation of intervention, on average 2 months
Other Comparison of RISQ scores among children with different clinical conditions in inpatient care Differences in RISQ scores among children with different clinical diagnoses a) on admission to inpatient care; b) throughout inpatient care; and c) at exit from inpatient care Duration of hospitalization in days up to 60 days
Primary All-cause mortality. Mortality over the period beginning at admission to the program and ending at either program discharge or to a maximum of 60 days after study enrolment. Program discharge will be one of: [1] medical/anthropometric criteria or [2] defaulting from the program.
Defaulting from the program is defined as children who do not attend the weekly clinic visits for 3 consecutive weeks.
12 months
Secondary Timing of inpatient mortality Timing will be defined as [a] within 48 hours of hospital admission and [b] timing of death after admission to hospital Duration of hospitalization in days up to 60 days
Secondary Timing of outpatient mortality Timing will be defined as [a] within 48 hours of being seen by health-care team [b] timing of death after being seen by outpatient health-care team Duration of program inclusion in days up to 60 days
Secondary Therapeutic intensity To be measured by location on admission to inpatient care (Intensive Care Unit/Phase1/Phase2) First 24 hours from admission to hospital
Secondary Efficiency of inpatient care Efficiency measured by length of inpatient stay (whole or part days) Duration of hospitalization in days up to 60 days
Secondary Workload Frontline staff perception of workload measured through questionnaires using a 5 point scale Month 1 and month 12
Secondary Knowledge Frontline staff knowledge of assessment skills measured through questionnaire using a 5 point scale Month 1 and month 12
Secondary Fidelity of RISQ Implementation Number of measured vital signs performed on individual patient at health centre visit with corresponding disposition in program, recorded in 10 randomly selected patients/week/health centre 12 months
Secondary Acceptability Acceptability of the RISQ System by front-line staff evaluated through a questionnaire using a 5 point scale Month 1 and month 12
See also
  Status Clinical Trial Phase
Completed NCT03360877 - Prevention of Nosocomial Infections (CleanKids) N/A
Completed NCT04715204 - Gastrointestinal Tolerance of Under-five Children With Severe Acute Malnutrition to ONS Compared to F-75/F-100 N/A
Not yet recruiting NCT06061484 - Modified Dosage for Severe Acute Malnutrition N/A
Not yet recruiting NCT06038071 - Family Mid-Upper Arm Circumference (MUAC) Follow-up After Recovery From Acute Malnutrition (MODAM-fMUAC) N/A
Completed NCT03666572 - Pilot of a Prebiotic and Probiotic Trial in Young Infants With Severe Acute Malnutrition Phase 2
Completed NCT05020847 - Effectiveness of Alternative Diets During the Stabilization Phase on Children With Complicated SAM N/A
Completed NCT05015257 - Effectiveness of Four Transition Dietary Regimens in the Hospital Management of Children With Kwashiorkor. N/A
Completed NCT03370003 - Non-routine Use of Antibiotics (Amoxi-light)
Completed NCT03303131 - SAM: Discharge Based on the Use of a MUAC-based Criterion to N/A
Recruiting NCT06002438 - Eggs for Gut Health N/A
Terminated NCT05473234 - Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria Phase 3
Completed NCT01613547 - The Effect of Routine Antibiotic Use in the Outpatient Treatment of Severely Malnourished Children Without Complications N/A
Completed NCT01331044 - Ready to Use Therapeutic Food (RUTF) in Severe Malnourished Children N/A
Completed NCT03094247 - Feeding Malnourished Children Different Types of Fatty Acids to Promote Neurocognitive Development N/A
Recruiting NCT04240990 - Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition N/A
Completed NCT01958905 - Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children N/A
Completed NCT05737472 - High-protein Quantity and Quality RUTF in Improving Linear Growth Among Children With Severe Wasting N/A
Completed NCT03716115 - Therapeutic Approaches to Malnutrition Enteropathy Phase 2
Completed NCT01593969 - A Trial of n-3 PUFA-Enriched Ready to Use Therapeutic Food for Childhood Severe Malnutrition Phase 2
Completed NCT05891457 - Changes in Nerve Electro Physiologic Properties in Children Before and After Correction of Malnutrition N/A